Skip to main content

A multi-cancer screening platform for fast and accurate early stage cancer detection from urine samples

Project description

Innovative screening for cancer detection in urine samples

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/clinical medicine/oncology/cancer
  • /natural sciences/computer and information sciences/artificial intelligence/machine learning

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

MDB DIAGNOSIS GROUP LIMITED
Address
Building 6 30 Friern Park
N12 9DA London
United Kingdom
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000